Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

H. Hanna, Nasser; Robinson, Andrew; Temin, Sarah; Baker, Sherman; R. Brahmer, Julie; M. Ellis, Peter; E. Gaspar, Laurie; Y. Haddad, Rami; J. Hesketh, Paul; Jain, Dharamvir; Jaiyesimi, Ishmael; H. Johnson, David; B. Leighl, Natasha; R. Moffitt, Pamela; Phillips, Tanyanika; J. Riely, Gregory; Rosell, Rafael; H. Schiller, Joan; J. Schneider, Bryan; Singh, Navneet; R. Spigel, David; Tashbar, Joan; A. Masters, Gregory

doi:10.1200/jco.20.03570

Public

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Published in Journal of Clinical Oncology • Feb 16, 2021

Authors:

Nasser H. Hanna

Andrew Robinson

Sarah Temin

Abstract

PURPOSE To provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC) with driver alterations. A guideline update for systemic therapy for patients with stage IV NSCLC without driver alterations was publis...

Subject

Medicine

Guideline

Lung cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!